However, loss-of-function variants in ANGPTL3 are associated with decreased plasma levels of TG, LDL-C, and HDL-C, as well as reduced ASCVD risk (Musunuru et al., 2012; Dewey et al., 2017). This evidence concerns the gene ANGPTL3 and atherosclerosis.